Published in Eur J Biochem on August 15, 1997
Predicting P-glycoprotein-mediated drug transport based on support vector machine and three-dimensional crystal structure of P-glycoprotein. PLoS One (2011) 1.17
Multidrug resistance: Physiological principles and nanomedical solutions. Adv Drug Deliv Rev (2013) 1.15
A predictive model for the selective accumulation of chemicals in tumor cells. Eur Biophys J (2005) 1.11
The small molecule Retro-1 enhances the pharmacological actions of antisense and splice switching oligonucleotides. Nucleic Acids Res (2013) 0.97
Rhodamine inhibitors of P-glycoprotein: an amide/thioamide "switch" for ATPase activity. J Med Chem (2009) 0.91
A plausible explanation for enhanced bioavailability of P-gp substrates in presence of piperine: simulation for next generation of P-gp inhibitors. J Mol Model (2012) 0.87
Kinetic analysis of rhodamines efflux mediated by the multidrug resistance protein (MRP1). Biophys J (2003) 0.81
On a biophysical and mathematical model of Pgp-mediated multidrug resistance: understanding the "space-time" dimension of MDR. Eur Biophys J (2009) 0.81
Thiorhodamines containing amide and thioamide functionality as inhibitors of the ATP-binding cassette drug transporter P-glycoprotein (ABCB1). Bioorg Med Chem (2012) 0.80
Cost, effectiveness and environmental relevance of multidrug transporters in sea urchin embryos. J Exp Biol (2013) 0.79
Optical imaging of tumors with copper-labeled rhodamine derivatives by targeting mitochondria. Theranostics (2012) 0.79
Characterization and evaluation of 5-fluorouracil-loaded solid lipid nanoparticles prepared via a temperature-modulated solidification technique. AAPS PharmSciTech (2014) 0.79
Solid lipid nanoparticles with TPGS and Brij 78: A co-delivery vehicle of curcumin and piperine for reversing P-glycoprotein-mediated multidrug resistance in vitro. Oncol Lett (2016) 0.75
Selenorhodamine photosensitizers for photodynamic therapy of P-glycoprotein-expressing cancer cells. J Med Chem (2014) 0.75
Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2. Cancer Res (1999) 1.72
Optimality score for the neurologic examination of the infant at 12 and 18 months of age. J Pediatr (1999) 1.72
Impaired bortezomib binding to mutant β5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells. Leukemia (2011) 1.29
Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells. Eur J Biochem (1999) 1.14
Ultrasound evolution and later outcome of infants with periventricular densities. Early Hum Dev (1988) 1.12
A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance. J Biol Chem (1998) 1.08
Cerebral ventricular dilation in congenital myotonic dystrophy. J Pediatr (1987) 1.03
Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability. Eur J Biochem (1995) 1.00
Krabbe disease: increased incidence in a highly inbred community. Am J Med Genet (1985) 0.99
Dexamethasone in neonatal chronic lung disease: pulmonary effects and intracranial complications. Eur J Pediatr (1989) 0.97
Polyamine levels and the activity of their biosynthetic enzymes in human erythrocytes infected with the malarial parasite, Plasmodium falciparum. Biochem J (1984) 0.97
Acquired resistance of human T cells to sulfasalazine: stability of the resistant phenotype and sensitivity to non-related DMARDs. Ann Rheum Dis (2004) 0.97
The role of minor subpopulations within the leukemic blast compartment of AML patients at initial diagnosis in the development of relapse. Leukemia (2012) 0.96
The development of the complement system after 28 weeks' gestation. Acta Paediatr (1997) 0.96
Late onset cystic leucomalacia. Arch Dis Child (1986) 0.96
Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers. Cell Death Dis (2012) 0.95
Cytostatic effect of DL-alpha-difluoromethylornithine against Plasmodium falciparum and its reversal by diamines and spermidine. Parasitol Res (1987) 0.94
The role of passive transbilayer drug movement in multidrug resistance and its modulation. J Biol Chem (1996) 0.94
Glu274Lys/Gly309Arg mutation of the tissue-nonspecific alkaline phosphatase gene in neonatal hypophosphatasia associated with convulsions. J Inherit Metab Dis (2002) 0.94
Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity. J Biol Chem (1996) 0.92
Effect of polyamine depletion on macromolecular synthesis of the malarial parasite, Plasmodium falciparum, cultured in human erythrocytes. Biochem J (1987) 0.92
The pattern of dihydrofolate reductase expression through the cell cycle in rodent and human cultured cells. J Biol Chem (1989) 0.92
Preclinical emergence of vandetanib as a potent antitumour agent in mesothelioma: molecular mechanisms underlying its synergistic interaction with pemetrexed and carboplatin. Br J Cancer (2011) 0.91
A mutated murine reduced folate carrier (RFC1) with increased affinity for folic acid, decreased affinity for methotrexate, and an obligatory anion requirement for transport function. J Biol Chem (1998) 0.90
Plasmodium falciparum: synchronization of cultures with DL-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis. Exp Parasitol (1986) 0.89
Localized cerebral infarction in the premature infant: an ultrasound diagnosis correlated with computed tomography and magnetic resonance imaging. Pediatrics (1988) 0.89
The effect of purified aminoaldehydes produced by polyamine oxidation on the development in vitro of Plasmodium falciparum in normal and glucose-6-phosphate-dehydrogenase-deficient erythrocytes. Biochem J (1986) 0.88
Predictive value of early continuous electroencephalogram monitoring in ventilated preterm infants with intraventricular hemorrhage. Pediatrics (1988) 0.86
Preterm labour at 34--36 weeks of gestation: should it be arrested? Paediatr Perinat Epidemiol (2001) 0.85
Perinatal risk factors for the development of extensive cystic leukomalacia. Am J Dis Child (1988) 0.84
Use of 23Na nuclear magnetic resonance spectroscopy to determine the true intracellular concentration of free sodium in a halophilic eubacterium. J Bacteriol (1991) 0.83
Multiple mechanisms of resistance to polyglutamatable and lipophilic antifolates in mammalian cells: role of increased folylpolyglutamylation, expanded folate pools, and intralysosomal drug sequestration. Mol Pharmacol (1999) 0.83
Alteration of mitochondrial gene expression and disruption of respiratory function by the lipophilic antifolate pyrimethamine in mammalian cells. J Biol Chem (1995) 0.83
Clustering of mutations in the first transmembrane domain of the human reduced folate carrier in GW1843U89-resistant leukemia cells with impaired antifolate transport and augmented folate uptake. J Biol Chem (2000) 0.83
Israel guidelines for the management of neonatal hyperbilirubinemia and prevention of kernicterus. J Perinatol (2008) 0.83
A reduced folate carrier mutation produces substrate-dependent alterations in carrier mobility in murine leukemia cells and methotrexate resistance with conservation of growth in 5-formyltetrahydrofolate. J Biol Chem (1998) 0.83
Flow cytometric characterization of antifolate resistance in cultured mammalian cells using fluoresceinated methotrexate and daunorubicin. Cancer Res (1990) 0.82
Transport of polypeptide ionophores into proteoliposomes reconstituted with rat liver P-glycoprotein. J Biol Chem (1994) 0.81
Evolution of periventricular leukomalacia during the neonatal period and infancy: correlation of imaging and postmortem findings. Early Hum Dev (1989) 0.81
Functional reconstitution of P-glycoprotein reveals an apparent near stoichiometric drug transport to ATP hydrolysis. J Biol Chem (1996) 0.81
Characterization of a human alternatively spliced truncated reduced folate carrier increasing folate accumulation in parental leukemia cells. Eur J Biochem (2000) 0.81
Targeting multidrug resistant tumor cells with a recombinant single-chain FV fragment directed to P-glycoprotein. Int J Cancer (2001) 0.80
Birth weight and physical ability in 5- to 8-yr-old healthy children born prematurely. Med Sci Sports Exerc (1997) 0.80
A phenotype conferring selective resistance to lipophilic antifolates in Chinese hamster ovary cells. Cancer Res (1991) 0.79
Re: Folylpolyglutamyl synthetase gene transfer and glioma antifolate sensitivity in culture and in vivo. J Natl Cancer Inst (1999) 0.79
Prenatal diagnosis of Krabbe disease using a fluorescent derivative of galactosylceramide. Clin Chim Acta (1984) 0.79
New tricks for old biomarkers: thymidylate synthase expression as a predictor of pemetrexed activity in malignant mesothelioma. Ann Oncol (2010) 0.78
Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells. Adv Enzyme Regul (1997) 0.77
Prenatal sonographic detection of a lipomeningocele as a sacral lesion. J Clin Ultrasound (2000) 0.77
Growth pattern in Krabbe's disease. Acta Paediatr Scand (1986) 0.77
Cells from chronic myelogenous leukaemia patients at presentation exhibit multidrug resistance not mediated by either MDR1 or MRP1. Br J Haematol (2001) 0.77
Methotrexate analogues display enhanced inhibition of TNF-α production in whole blood from RA patients. Scand J Rheumatol (2013) 0.76
Perinatal group B streptococcal infections in Israel. Isr J Med Sci (1983) 0.76
Continuous four-channel EEG monitoring in the evaluation of echodense ultrasound lesions and cystic leucomalacia. Arch Dis Child (1987) 0.75
Corneal opacity due to intrauterine trauma following a motor vehicle accident. J Pediatr Ophthalmol Strabismus (1999) 0.75
[The handicapped newborn infant: an experienced multidisciplinary team approach for family support]. Harefuah (1990) 0.75
Reduced folate carrier (RFC-1) gene expression in normal and psoriatic skin. Arch Dermatol Res (1998) 0.75
Dichloroacetate treatment for severe refractory metabolic acidosis during neonatal sepsis. Pediatr Infect Dis J (2001) 0.75
[CMV infections in the mother and newborn]. Harefuah (1991) 0.75
Dexamethasone and increased intracranial echogenicity. Lancet (1987) 0.75
Familial perinatal hemochromatosis: a disease that causes recurrent non-immune hydrops. J Perinat Med (1999) 0.75
The reduced folate carrier (RFC-1) gene is expressed in the murine epidermis. Arch Dermatol Res (1998) 0.75
[Hypertriglyceridemia and diabetes]. Harefuah (1980) 0.75
Polyamines in the cell cycle of the malarial parasite Plasmodium falciparum. Adv Exp Med Biol (1988) 0.75
Effect of surfactant replacement therapy on the outcome of premature infants with respiratory distress syndrome. Isr J Med Sci (1994) 0.75